|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.00 INR | +0.53% |
|
+0.53% | -9.74% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 91.84 |
| Change | - |
| Enterprise Value (EV) 1 | 61.1 |
| Change | - |
| P/E Ratio | 21.2x |
| PBR | 1.04x |
| PEG | -1.1x |
| Capitalization / Revenue | 1.12x |
| EV / Revenue | 0.74x |
| EV / EBITDA | 7.09x |
| EV / EBIT | 14.8x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | 1.896 |
| Distribution rate | - |
| Net sales 1 | 82.35 |
| EBITDA 1 | 8.62 |
| EBIT 1 | 4.122 |
| Net income 1 | 3.947 |
| Net Debt 1 | -30.75 |
| Reference price 2 | 40.24 |
| Nbr of stocks (in thousands) | 2,282 |
| Announcement Date | 26/08/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 917K | |
| -132.89x | 10.9x | -150.84x | -.--% | 31.52B | |
| 15.9x | 1.26x | 7.17x | 5.52% | 6.87B | |
| 289.79x | - | - | - | 4.44B | |
| 54.12x | 9.56x | 33.56x | 0.85% | 2.9B | |
| -20.22x | - | - | - | 1.8B | |
| 28.91x | 1.17x | 9.62x | 0.87% | 1.67B | |
| 33.31x | 1.45x | 11.79x | 1.62% | 1.67B | |
| 11.64x | 1.24x | 4.85x | 6.5% | 1.58B | |
| 17.64x | 7.31x | 11.77x | 2.1% | 1.51B | |
| Average | 33.13x | 4.70x | -10.30x | 2.49% | 5.4B | |
| Weighted average by Cap. | -46.75x | 8.33x | -95.28x | 1.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
